Anjali Cremer

SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia

Constanze Schneider, Thomas Oellerich, Hanna‐Mari Baldauf et al. · Nature Medicine · 2016 · 166 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +8

The proteogenomic subtypes of acute myeloid leukemia

Ashok Kumar Jayavelu, Sebastian Wolf, Florian Buettner et al. · Cancer Cell · 2022 · 131 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Genetics +4

Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia

Sebastian Mohr, Carmen Doebele, Federico Comoglio et al. · Cancer Cell · 2017 · 112 citations · Full text

FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation

Thomas Oellerich, Sebastian Mohr, Jasmin Corso et al. · Blood · 2015 · 56 citations · Full text

IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia

Brandon J. Aubrey, Jevon Cutler, Wallace Bourgeois et al. · Nature Cancer · 2022 · 55 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Malignant Blood Disorder +6